GO:0048145 regulation of fibroblast proliferation: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0048145 (regulation of fibroblast proliferation) describes any process that modulates the frequency, rate or extent of fibroblast multiplication.
• Fibroblast proliferation is controlled by growth factors, metabolic cues, non-coding RNAs and immune-microenvironment signals.
• Dysregulated fibroblast proliferation drives fibrosis in lung, kidney, heart and skin, and also influences tissue repair and regeneration.
• Non-coding RNAs such as circIGF1R and LincRNA-EPS directly regulate fibroblast proliferation through metabolic and cell-cycle mechanisms.
• Pharmacological and nanoparticle-based interventions can attenuate fibroblast proliferation and activation, offering antifibrotic strategies.
• CRISPR knockout, knock-in, point-mutation and overexpression models are essential to causally test genes that regulate fibroblast proliferation.
Description
Fibroblasts are the principal mesenchymal cells responsible for producing and remodeling the extracellular matrix, and their proliferation must be tightly regulated to maintain tissue homeostasis. The Gene Ontology term GO:0048145, regulation of fibroblast proliferation, captures any process that modulates the frequency, rate or extent of fibroblast multiplication. This term is central to understanding how tissues respond to injury, how fibrosis develops, and how regenerative medicine can be optimized. Research over the past decade has revealed that fibroblast proliferation is not a single linear pathway but a convergence point for growth factor signaling, metabolic reprogramming, non-coding RNA networks and immune cell crosstalk. For example, circular RNA circIGF1R controls cardiac fibroblast proliferation through regulation of carbohydrate metabolism, while LincRNA-EPS promotes proliferation of aged dermal fibroblasts by inducing CCND1. These findings illustrate that GO:0048145 encompasses diverse molecular mechanisms that can be targeted experimentally. For researchers, GO:0048145 provides a standardized framework to annotate and compare experimental results across tissues and disease models. Whether studying penile erection, cardiac fibrosis, diabetic wound healing or lung fibrosis, the regulation of fibroblast proliferation is a recurring theme that links basic cell biology to translational applications.
regulation of fibroblast proliferation At A Glance
| GO ID | GO:0048145 |
|---|---|
| GO term | regulation of fibroblast proliferation |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the frequency, rate or extent of fibroblast multiplication or reproduction |
| Biological context | Tissue repair, fibrosis, regeneration, immune-microenvironment interactions |
| Key molecular players | Growth factors, non-coding RNAs, cell-cycle regulators such as CCND1, metabolic enzymes |
| Disease relevance | Lung fibrosis, renal fibrosis, cardiac fibrosis, diabetic wound healing, tissue regeneration |
What Is GO:0048145?
GO:0048145, regulation of fibroblast proliferation, is defined as any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells. In practical terms, it includes signaling events, transcriptional programs, metabolic changes and cell-cycle checkpoints that either promote or restrain fibroblast division.
Why Is regulation of fibroblast proliferation Important in Cell Biology?
Regulation of fibroblast proliferation is a fundamental biological process because fibroblasts are the primary matrix-producing cells in connective tissue, and their expansion or quiescence determines whether tissues heal, scar or regenerate. Dysregulated fibroblast proliferation contributes to fibrotic diseases in multiple organs, including lung, kidney and heart, where excessive fibroblast accumulation leads to organ dysfunction. Conversely, insufficient fibroblast proliferation can impair wound healing, as seen in diabetic wounds. Understanding GO:0048145 therefore has direct implications for antifibrotic drug development, regenerative medicine and cancer stroma biology.
• Fibroblast proliferation is a hallmark of tissue repair and fibrosis across organs.
• Cardiac fibroblast proliferation contributes to adverse remodeling after myocardial injury.
• Lung fibroblast activation and proliferation are central to pulmonary fibrosis pathogenesis.
• Renal fibroblast proliferation drives kidney fibrosis and chronic kidney disease progression.
• Dermal fibroblast proliferation is critical for skin wound healing and aging-related repair deficits.
• Non-coding RNAs such as circIGF1R and LincRNA-EPS provide new layers of proliferative control.
• Immune-microenvironment interactions regulate fibroblast proliferation during regeneration.
• Pharmacological inhibition of fibroblast proliferation, e.g., via Galectin-1 or dihydroartemisinin, attenuates fibrosis.
• Nanoparticle-based therapies can modulate multicellular networks to promote diabetic wound healing.
• CRISPR-based models enable causal testing of genes that regulate fibroblast proliferation.
What Happens During regulation of fibroblast proliferation?
Initiation by Growth Factors and Environmental Cues
In simple terms: Fibroblasts start dividing when they receive external signals, such as growth factors or mechanical cues.
Regulation of fibroblast proliferation begins with extracellular signals that include growth factors, cytokines and matrix stiffness. In the corpus cavernosum, fibroblasts mediate penile erection through signaling interactions that influence their proliferative state. Immune-microenvironment interactions also provide cues that regulate fibroblast proliferation during tissue regeneration. These initiating signals converge on receptor tyrosine kinases and downstream pathways that prepare the cell for division.
Metabolic Reprogramming and Non-coding RNA Control
In simple terms: Cells change their metabolism and use non-coding RNAs to decide whether to divide.
Circular RNA circIGF1R controls cardiac fibroblast proliferation through regulation of carbohydrate metabolism, linking metabolic flux to proliferative capacity. Similarly, LincRNA-EPS promotes proliferation of aged dermal fibroblasts by inducing CCND1, a key cell-cycle regulator. These examples show that non-coding RNAs and metabolic pathways are integral to the regulation of fibroblast proliferation.
Cell-Cycle Entry and Proliferation
In simple terms: Once the decision to divide is made, fibroblasts enter the cell cycle and multiply.
The ultimate outcome of regulation of fibroblast proliferation is the modulation of cell-cycle entry and progression. CCND1 induction by LincRNA-EPS directly promotes proliferation in aged dermal fibroblasts. In cardiac fibroblasts, distinct protein kinase C isoforms differentially regulate proliferation and transdifferentiation, indicating that cell-cycle control is tightly linked to signaling identity. This stage determines the net increase or decrease in fibroblast number.
Inhibition and Resolution of Proliferation
In simple terms: Proliferation can be stopped by inhibitory signals to prevent excessive scarring.
Negative regulation of fibroblast proliferation is essential to resolve repair and prevent fibrosis. Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. These findings demonstrate that pharmacological or genetic inhibition of proliferative pathways can limit fibrotic progression.
Integration with Tissue Regeneration and Immune Microenvironment
In simple terms: Fibroblast proliferation is coordinated with immune cells and tissue regeneration programs.
Regulation of fibroblast proliferation does not occur in isolation; it is integrated with immune-microenvironment interactions that govern tissue regeneration. Turmeric-derived nanoparticle-functionalized aerogel regulates multicellular networks to promote diabetic wound healing, highlighting how fibroblast proliferation can be modulated in a regenerative context. Thus, the process is embedded in a broader multicellular network that determines tissue outcomes.
Key Genes Involved in GO:0048145 regulation of fibroblast proliferation
The following genes and non-coding RNAs have been experimentally linked to the regulation of fibroblast proliferation in the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CCND1 | Cell-cycle regulator induced by LincRNA-EPS | Promotes proliferation of aged dermal fibroblasts |
| circIGF1R | Circular RNA regulating carbohydrate metabolism | Controls cardiac fibroblast proliferation |
| LincRNA-EPS | Long intergenic non-coding RNA | Promotes proliferation of aged dermal fibroblasts via CCND1 |
| LGALS1 (Galectin-1) | Galectin family lectin | Inhibition attenuates lung fibroblast activation and proliferation |
| PKC isoforms | Protein kinase C family members | Differentially regulate cardiac fibroblast proliferation and transdifferentiation |
| IGF1R | Insulin-like growth factor 1 receptor | Parent gene of circIGF1R involved in cardiac fibroblast proliferation |
| Dihydroartemisinin target pathways | Antifibrotic signaling | Regulates renal fibroblast proliferation and differentiation |
| Immune microenvironment factors | Cytokines and immune cell signals | Regulate fibroblast proliferation during tissue regeneration |
| Corpora cavernosa fibroblast signaling molecules | Erection-related signaling | Mediate penile erection via fibroblast regulation |
| Turmeric-derived nanoparticle targets | Multicellular network regulators | Promote diabetic wound healing via fibroblast proliferation modulation |
| CCND1-associated kinases | Cell-cycle kinases | Potential targets for modulating fibroblast proliferation |
| Metabolic enzymes in carbohydrate metabolism | Glycolysis and related pathways | Linked to circIGF1R-mediated cardiac fibroblast proliferation |
| Galectin-1 downstream effectors | Fibrosis-associated signaling | Mediate lung fibroblast activation and proliferation |
| PKC classical isoforms | Serine/threonine kinases | Regulate cardiac fibroblast proliferation |
| PKC novel isoforms | Serine/threonine kinases | Distinct roles in cardiac fibroblast transdifferentiation |
| Renal fibroblast differentiation markers | Fibrosis markers | Modulated by dihydroartemisinin |
| Dermal fibroblast aging factors | Senescence-associated pathways | Targeted by LincRNA-EPS to restore proliferation |
| Wound healing multicellular network components | Aerogel-responsive cells | Regulated by turmeric-derived nanoparticles |
How Is regulation of fibroblast proliferation Regulated?
Regulation of fibroblast proliferation is controlled at multiple levels, including growth factor signaling, non-coding RNA networks and metabolic pathways. CircIGF1R regulates cardiac fibroblast proliferation through carbohydrate metabolism, indicating metabolic control. LincRNA-EPS induces CCND1 to promote proliferation in aged dermal fibroblasts, linking non-coding RNA to cell-cycle machinery. Protein kinase C isoforms differentially regulate cardiac fibroblast proliferation and transdifferentiation, showing that signaling identity determines proliferative outcomes. Immune-microenvironment interactions further modulate fibroblast proliferation during tissue regeneration. Pharmacological agents such as Galectin-1 inhibitors and dihydroartemisinin can suppress fibroblast proliferation in fibrosis models.
regulation of fibroblast proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LGALS1 (Galectin-1) | Lung fibrosis | Knockout or knockdown in lung fibroblast cultures and bleomycin-induced fibrosis models |
| circIGF1R | Cardiac fibrosis | Overexpression or knockdown in cardiac fibroblasts and metabolic assays |
| LincRNA-EPS | Aged dermal fibroblast dysfunction | Overexpression in aged dermal fibroblasts and wound healing models |
| PKC isoforms | Cardiac fibrosis and transdifferentiation | Isoform-specific knockout or point-mutation in cardiac fibroblasts |
| Dihydroartemisinin targets | Renal fibrosis | Pharmacological intervention in renal fibroblast and kidney fibrosis models |
Fibrosis in Lung, Kidney and Heart
Dysregulated fibroblast proliferation is a central mechanism in organ fibrosis. Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. In the heart, distinct protein kinase C isoforms regulate cardiac fibroblast proliferation and transdifferentiation, with implications for new antifibrotic therapies. These studies demonstrate that targeting proliferative pathways can limit fibrotic progression.
Tissue Repair and Diabetic Wound Healing
Fibroblast proliferation is essential for effective wound healing, and its impairment contributes to chronic wounds. Turmeric-derived nanoparticle-functionalized aerogel regulates multicellular networks to promote diabetic wound healing, highlighting the therapeutic potential of modulating fibroblast proliferation. Aged dermal fibroblasts show reduced proliferative capacity, which can be rescued by LincRNA-EPS via CCND1 induction. Thus, enhancing fibroblast proliferation in a controlled manner may improve healing outcomes.
Regeneration and Immune-Microenvironment Interactions
Regulation of fibroblast proliferation is integrated with immune responses during tissue regeneration. Immune-microenvironment-fibroblast interactions regulate tissue regeneration, indicating that inflammatory signals can either promote or restrain fibroblast expansion. In the corpus cavernosum, fibroblasts mediate penile erection, linking fibroblast function to physiological processes beyond fibrosis. Understanding these interactions may reveal new regenerative strategies.
Cardiac Fibrosis and Metabolic Control
Cardiac fibroblast proliferation is regulated by metabolic and non-coding RNA mechanisms. CircIGF1R controls cardiac fibroblast proliferation through regulation of carbohydrate metabolism, suggesting that metabolic interventions could modulate fibrosis. Protein kinase C isoforms also differentially regulate cardiac fibroblast proliferation, providing additional targets. These findings underscore the complexity of fibroblast regulation in heart disease.
From regulation of fibroblast proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for fibroblast proliferation? | CRISPR knockout in primary fibroblasts or fibroblast cell lines |
| Does a specific point mutation alter proliferative signaling? | CRISPR point-mutation knock-in in fibroblasts |
| Does overexpression of a non-coding RNA promote proliferation? | CRISPR knock-in or lentiviral overexpression of circIGF1R or LincRNA-EPS |
| Can a tagged protein be used to track proliferation regulators? | Tagged knock-in of CCND1 or PKC isoforms |
| Does pharmacological inhibition reduce fibroblast proliferation? | Small-molecule treatment in lung or renal fibroblast cultures |
| Can nanoparticle-based systems modulate fibroblast proliferation in vivo? | Diabetic wound healing models treated with functionalized aerogel |
How to Study the regulation of fibroblast proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis and cell proliferation | Quantifying fibroblast proliferation after gene knockout or drug treatment |
| RNA sequencing | Transcriptome and non-coding RNA expression | Identifying regulators such as circIGF1R and LincRNA-EPS |
| Seahorse extracellular flux | Glycolysis and oxidative phosphorylation | Linking carbohydrate metabolism to cardiac fibroblast proliferation |
| Immunofluorescence | Protein localization and proliferation markers | Detecting Ki-67 in fibroblasts within tissues |
| Western blot | Protein expression and signaling activation | Validating CCND1 induction or PKC isoform effects |
| CRISPR screening | Gene function at scale | Discovering novel regulators of fibroblast proliferation |
| qRT-PCR | Gene expression levels | Measuring non-coding RNA and mRNA changes |
| Histology | Tissue architecture and fibrosis | Assessing fibroblast proliferation in organ fibrosis models |
Cell Proliferation Assays
Standard methods to measure fibroblast proliferation include EdU incorporation, BrdU labeling, MTT assays and real-time cell analysis. These assays are used to quantify the effects of genetic or pharmacological perturbations on fibroblast multiplication, as demonstrated in studies of Galectin-1 inhibition and dihydroartemisinin treatment.
RNA Sequencing and Non-coding RNA Profiling
RNA sequencing can identify differentially expressed genes and non-coding RNAs that regulate fibroblast proliferation. For example, circIGF1R and LincRNA-EPS were discovered through such approaches and functionally validated in cardiac and dermal fibroblasts. Bioinformatics analysis of RNA-seq data helps prioritize candidate regulators for CRISPR validation.
Metabolic Flux Analysis
Because circIGF1R controls cardiac fibroblast proliferation through carbohydrate metabolism, metabolic assays such as glucose uptake, lactate production and Seahorse extracellular flux analysis are valuable to link metabolism to proliferation. These methods reveal how metabolic reprogramming supports fibroblast division.
Imaging and Histology
Immunofluorescence and immunohistochemistry for proliferation markers such as Ki-67 or PCNA, combined with fibroblast-specific markers, allow spatial assessment of fibroblast proliferation in tissues. These methods are essential for validating in vitro findings in animal models of fibrosis and wound healing.
How CRISPR Can Be Used to Study GO:0048145 regulation of fibroblast proliferation
Knockout
CRISPR knockout is used to delete candidate genes such as LGALS1 or PKC isoforms to test their requirement for fibroblast proliferation. For example, knockout of Galectin-1 or its inhibition attenuates lung fibroblast activation and proliferation. Knockout of circIGF1R or its parent gene IGF1R can reveal its role in cardiac fibroblast proliferation.
Point Mutation
CRISPR point mutation can introduce specific amino acid changes to dissect signaling domains. For instance, mutating phosphorylation sites in PKC isoforms may clarify their differential roles in cardiac fibroblast proliferation and transdifferentiation. Point mutations in CCND1 regulatory regions could affect its induction by LincRNA-EPS.
Knock-in
Knock-in of tagged versions of CCND1 or PKC isoforms allows tracking of protein localization and interactions during fibroblast proliferation. Knock-in of non-coding RNA expression cassettes, such as LincRNA-EPS, can rescue proliferation in aged dermal fibroblasts.
Overexpression
CRISPR overexpression via knock-in of strong promoters or lentiviral delivery can test sufficiency of a gene to drive fibroblast proliferation. Overexpression of circIGF1R or LincRNA-EPS promotes cardiac and dermal fibroblast proliferation, respectively. Overexpression models are also useful for studying metabolic regulators of proliferation.
How EDITGENE Supports regulation of fibroblast proliferation Research
Researchers studying regulation of fibroblast proliferation-related genes often need to determine whether a candidate gene is causally involved in fibroblast multiplication or is merely correlated with proliferative changes. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional validation of genes implicated in GO:0048145.
Contact EDITGENE today to design your custom CRISPR model for regulation of fibroblast proliferation research.
Frequently Asked Questions About regulation of fibroblast proliferation
What is GO:0048145 regulation of fibroblast proliferation?
GO:0048145 is a Gene Ontology biological process term defined as any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells.
What genes are involved in regulation of fibroblast proliferation?
Genes and non-coding RNAs such as CCND1, circIGF1R, LincRNA-EPS, LGALS1 and PKC isoforms have been experimentally linked to fibroblast proliferation.
How is fibroblast proliferation regulated in cardiac fibrosis?
CircIGF1R controls cardiac fibroblast proliferation through carbohydrate metabolism, and PKC isoforms differentially regulate proliferation and transdifferentiation.
What role does LincRNA-EPS play in fibroblast proliferation?
LincRNA-EPS promotes proliferation of aged dermal fibroblasts by inducing CCND1.
Can fibroblast proliferation be inhibited to treat fibrosis?
Yes, inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation, and dihydroartemisinin attenuates renal fibrosis by regulating fibroblast proliferation.
How do immune cells influence fibroblast proliferation?
Immune-microenvironment-fibroblast interactions regulate tissue regeneration, indicating that immune signals modulate fibroblast proliferation.
What methods are used to study regulation of fibroblast proliferation?
Common methods include EdU/BrdU incorporation, RNA sequencing, metabolic flux analysis, immunofluorescence and CRISPR screening.
What is the role of fibroblasts in penile erection?
Corpora cavernosa fibroblasts mediate penile erection, highlighting physiological roles beyond fibrosis.
How can CRISPR be used to study fibroblast proliferation genes?
CRISPR knockout, point mutation, knock-in and overexpression models allow causal testing of genes such as LGALS1, CCND1 and PKC isoforms in fibroblast proliferation.
What experimental models are suitable for studying fibroblast proliferation?
Primary fibroblast cultures, organ fibrosis models, wound healing models and CRISPR-engineered cell lines are commonly used.
Conclusion
GO:0048145 regulation of fibroblast proliferation is a critical biological process that integrates growth factor signaling, non-coding RNA networks, metabolic reprogramming and immune-microenvironment interactions. Its dysregulation underlies fibrosis in multiple organs and impaired wound healing, making it a prime target for therapeutic intervention. Advances in CRISPR-based models and high-throughput screening now enable precise causal dissection of the genes and pathways that control fibroblast proliferation. EDITGENE's knockout, point-mutation, knock-in, overexpression and library screening services provide researchers with the tools needed to accelerate discovery in this field.
References
- 1. Guimaraes EL et al.. 2024. Corpora cavernosa fibroblasts mediate penile erection.. Science 383(6683):eade8064 PMID: 38330107
- 2. Schmidt A et al.. 2025. Circular RNA circIGF1R controls cardiac fibroblast proliferation through regulation of carbohydrate metabolism.. Sci Rep 15(1):20331 PMID: 40579400
- 3. Zhang L et al.. 2024. LincRNA-EPS Promotes Proliferation of Aged Dermal Fibroblast by Inducing CCND1.. Int J Mol Sci 25(14) PMID: 39062918
- 4. Son B. 2025. Regulation of Tissue Regeneration by Immune Microenvironment-Fibroblast Interactions.. Int J Mol Sci 26(24) PMID: 41465375
- 5. Xue J et al.. 2023. Inhibition of Galectin-1 attenuates lung fibroblast activation and proliferation in lung fibrosis.. Cell Mol Biol (Noisy-le-grand) 69(11):213-218 PMID: 38015516
- 6. Zhang B et al.. 2019. Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation.. Life Sci 223:29-37 PMID: 30862567
- 7. Karhu ST et al.. 2021. Distinct Regulation of Cardiac Fibroblast Proliferation and Transdifferentiation by Classical and Novel Protein Kinase C Isoforms: Possible Implications for New Antifibrotic Therapies.. Mol Pharmacol 99(2):104-113 PMID: 33239332
- 8. Wu B et al.. 2024. Turmeric-Derived Nanoparticles Functionalized Aerogel Regulates Multicellular Networks to Promote Diabetic Wound Healing.. Adv Sci (Weinh) 11(18):e2307630 PMID: 38441389
